Principal Scientist, Biomarker Lead / Translational Scientist

THE COMPANY

Celsius Therapeutics is a biotechnology company developing novel precision medicines  autoimmune disease and cancer by harnessing the power of single cell RNA sequencing and human biology at scale. We are a community of scientists and business professionals aspiring to develop life-changing precision medicines. Our common goal is to markedly improve human health by integrating data, experience and insight.  Our environment is rigorous, fast-paced and collaborative, bringing together passionate individuals who are making an impact. We inspire creativity and discovery by embracing an open culture that fosters innovation, teamwork, and excellence. The company’s first therapeutic candidate is an anti-TREM1 antibody for the treatment of inflammatory bowel disease, and the company has multiple ongoing drug discovery programs in oncology. 

 

POSITION OVERVIEW

We seek a highly creative and experienced biomarker lead to and translate these assays into clinical trials. In collaboration with the project teams, you will define the strategy for development of scientifically rigorous translational and exploratory biomarker strategies that enable patient selection and/or assess proof of mechanism, target engagement, exploratory signs of efficacy. 

 

RESPONSIBILITIES

  • In collaboration with the project teams, define the strategy for development of scientifically rigorous translational and exploratory biomarker strategies that enable patient selection and/or assess proof of mechanism, target engagement, exploratory signs of efficacy
  • Drive method development and method transfer of internally developed assays to external vendors to ensure compliance and high quality data. Partner with CROs to ensure successful transfer and validation for use in clinical trials
  • Evaluate CROs for their ability to execute biomarker plans in the clinic
  • Support clinical studies as a biomarker lead, overseeing work by CROs to ensure quality execution and analysis, including managing and monitoring sample collection and analysis, and coordinating data analysis, interpretation and reporting of results
  • Support scientific input and review of all biomarker aspects of clinical and regulatory documents for early stage programs, including but not limited to study protocols

 

QUALIFICATIONS

  • Requires an advanced degree (PhD, MD) in life sciences or related area with significant prior experience (7+ years) or Masters degree (with 12+ years experience) in biomarker strategy and assay implementation.
  • Experience in PD biomarkers required, experience with patient selection biomarkers including CDx preferred
  • Demonstrated success in collaborating with CROs
  • Successful assay development for novel biomarkers and transfer to the clinic, including method development, method transfer and validation
  • Demonstration of use of biomarkers in a clinical setting, translation from pre-clinical to clinical studies
  • Demonstrated strong leadership, collaboration, and communication skills. Must be self-aware, inspiring, and able to skillfully bring people together to accomplish ambitious goals.

 

Celsius Therapeutics, Inc. is committed to providing equal employment opportunities to all employees and applicants for employment without regard to race, color, religion, sex, sexual orientation, national origin, age, disability, genetic information, status as a veteran or as a member of the military or status in any group protected by applicable federal or state laws.

 

Apply for this Job

* Required
resume chosen  
(File types: pdf, doc, docx, txt, rtf)
cover_letter chosen  
(File types: pdf, doc, docx, txt, rtf)


Voluntary Self-Identification

For government reporting purposes, we ask candidates to respond to the below self-identification survey. Completion of the form is entirely voluntary. Whatever your decision, it will not be considered in the hiring process or thereafter. Any information that you do provide will be recorded and maintained in a confidential file.

As set forth in Celsius Therapeutics’s Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law.

Race & Ethnicity Definitions

If you believe you belong to any of the categories of protected veterans listed below, please indicate by making the appropriate selection. As a government contractor subject to the Vietnam Era Veterans Readjustment Assistance Act (VEVRAA), we request this information in order to measure the effectiveness of the outreach and positive recruitment efforts we undertake pursuant to VEVRAA. Classification of protected categories is as follows:

A "disabled veteran" is one of the following: a veteran of the U.S. military, ground, naval or air service who is entitled to compensation (or who but for the receipt of military retired pay would be entitled to compensation) under laws administered by the Secretary of Veterans Affairs; or a person who was discharged or released from active duty because of a service-connected disability.

A "recently separated veteran" means any veteran during the three-year period beginning on the date of such veteran's discharge or release from active duty in the U.S. military, ground, naval, or air service.

An "active duty wartime or campaign badge veteran" means a veteran who served on active duty in the U.S. military, ground, naval or air service during a war, or in a campaign or expedition for which a campaign badge has been authorized under the laws administered by the Department of Defense.

An "Armed forces service medal veteran" means a veteran who, while serving on active duty in the U.S. military, ground, naval or air service, participated in a United States military operation for which an Armed Forces service medal was awarded pursuant to Executive Order 12985.


Form CC-305

OMB Control Number 1250-0005

Expires 05/31/2023

Voluntary Self-Identification of Disability

Why are you being asked to complete this form?

We are a federal contractor or subcontractor required by law to provide equal employment opportunity to qualified people with disabilities. We are also required to measure our progress toward having at least 7% of our workforce be individuals with disabilities. To do this, we must ask applicants and employees if they have a disability or have ever had a disability. Because a person may become disabled at any time, we ask all of our employees to update their information at least every five years.

Identifying yourself as an individual with a disability is voluntary, and we hope that you will choose to do so. Your answer will be maintained confidentially and not be seen by selecting officials or anyone else involved in making personnel decisions. Completing the form will not negatively impact you in any way, regardless of whether you have self-identified in the past. For more information about this form or the equal employment obligations of federal contractors under Section 503 of the Rehabilitation Act, visit the U.S. Department of Labor’s Office of Federal Contract Compliance Programs (OFCCP) website at www.dol.gov/ofccp.

How do you know if you have a disability?

You are considered to have a disability if you have a physical or mental impairment or medical condition that substantially limits a major life activity, or if you have a history or record of such an impairment or medical condition.

Disabilities include, but are not limited to:

  • Autism
  • Autoimmune disorder, for example, lupus, fibromyalgia, rheumatoid arthritis, or HIV/AIDS
  • Blind or low vision
  • Cancer
  • Cardiovascular or heart disease
  • Celiac disease
  • Cerebral palsy
  • Deaf or hard of hearing
  • Depression or anxiety
  • Diabetes
  • Epilepsy
  • Gastrointestinal disorders, for example, Crohn's Disease, or irritable bowel syndrome
  • Intellectual disability
  • Missing limbs or partially missing limbs
  • Nervous system condition for example, migraine headaches, Parkinson’s disease, or Multiple sclerosis (MS)
  • Psychiatric condition, for example, bipolar disorder, schizophrenia, PTSD, or major depression

PUBLIC BURDEN STATEMENT: According to the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless such collection displays a valid OMB control number. This survey should take about 5 minutes to complete.